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followed by translations only spinal cord registration. The difference 
between translations of vertebral and spinal cord registrations was 
analyzed (LR, AP, CC) as a measure for spinal cord movement within 
the CSF. 
Results: Reproducibility of registration differences was good; on 
average 0.03±0.1 mm (LR, AP) and -0.2±0.4mm (CC) at T8. Opposing 
WFS (LR, AP) of 2x1.1 mm translate into corresponding registration 
differences of 1.7±0.1 mm in the T1 scans (Figure 1). Opposing 0.3 
mm WFS for T2 scans could not be detected in registration 
differences. The cine MR images did not show spinal cord movement 
due to respiration (or respiration induced susceptibility changes). 
Positioning effects could not be distinguished within reproducibility 
for C7, T8 and L2. For L2, reproducibility was poorer in CC direction 
(SD 1.5 mm), possibly related to the more ambiguously defined equina 
cauda. In two participants, this caused spurious larger registration 
differences in AP and CC directions. 
 
Figure 1. Respective influences of reversed WFS (above, T1 scan) and 
subject repositioning (below, T2 scan) on (perceived) spinal cord 
position inside the spinal canal. For both figures, a grey value match 
on the vertebral body was performed. The WFS is clearly visible in the 
spinal cord area, whereas no effect of repositioning can be observed. 
Conclusions: MR properties and artefacts may influence perceived 
spinal cord location, which may be misleading in determination of 
spinal cord movement within the spinal canal. The robustness of the 
spinal cord position inside the spinal canal against respiration, 
repositioning and spine orientation suggests that the geometric 
accuracy of SRS for spinal oligometastasis remains uncompromised 
within a voxel. 
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Purpose/Objective: The accuracy preoperative staging is crucial for 
esophageal carcinoma treatment. In this study we evaluate the 
capability of diagnostic information provided by 18F-fluoro-
deoxyglucose positron tomography/computed tomography and 18F-
fluorothymidine positron tomography/ computed tomography in 
esophageal squamous cell carcinoma(ESCC) staging. We also evaluate 
whether 18F-FLT PET has the same performance in esophageal tumor 
stage comparing 18F-FDG PET/CT. The advantages and disadvantages 
of 18F-FDG PET/CT and 18F-FLT/CT were preliminary investigated. 
Surgical resection was performed and relationship between PET/CT 
and tumor histology was explored to verify the recognition accuracy of 
preoperative PET/CT.  
Materials and Methods: 26 patients with newly diagnosed ESCC 
underwent preoperative FDG FLT whole-body PET/CT separately. The 
correlation of the same patient’s FDG, FLT SUV and texture 
parameters were investigated using Pearson correlation. Then all 
patients received surgical resection and pathological types were 
obtained. We compare the stage conducted based on PET/CT with 
pathology types to assessing the capability of PET/CT in the 
esophageal squamous cell carcinoma. 
Results: FDG and FLT SUV have obvious correlation value r 
approximately 0.7 and p<0.01. However, only Entropy and Correlation 
have significant relationship between FDG and FLT PET images in 
texture parameters. In tumor stage SUV, texture parameters and 
shape feature have significant difference in corresponding histological 
tumor types and the results were verified accurate after operation. 
Conclusions: The FDG and FLT PET scans have their own advantages 
for ESCC stage as both the radiotracers can reflect the proliferation of 
tumor cells. The PET/CT characteristics have their own moderately 
capability for different type esophageal staging.  
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Purpose/Objective: In recent years, there have been big 
improvements in the treatment of head and neck cancer (HNC), but 
local relapse rates are still higher than in other malignant pathologies. 
Functional studies from PET/CT and MRI are the most promising 
techniques for measuring tumour response and individualising 
treatment. In our hospital, we started a research project (2012-2014) 
focused on quantifying tumour response of HNC patients (#50) by 
serial PET/CT and MRI (Apparent Diffusion Coefficient - ADC). The aim 
of this paper is to present the methodology of the project as well as 
the preliminary results of the two first patients included in the study 
which are used to test the procedure. 
Materials and Methods: For this study we select patients with 
'oropharynx T3 and T4'. All of them will be treated with IMRT (S&S). 
The standard dose to the PTV is 66 Gy. The imaging protocol will be as 
follows: 
-Pre-treatment: MRI study (1.5T Philips Achieva; single-shot echo-
planar diffusion-weighted MR sequence with different b-values) and 
PET/CT study (Whole-body PET/CT,370 MBq of 18F-FDG; GE Discovery 
STE 16). These images will be used for contouring and treatment 
planning. 
- First control (10 - 20 Gy ): MRI diffusion study. 
- Second control (20 Gy – 30 Gy): MRI diffusion study.  
- Three months after the end of the treatment: PET/CT and MRI 
diffusion study. 
For all the studies the patient is positioned using the RT 
immobilisation devices to ease image registration. The geometrical 
distortion on MRI images was checked. Therefore only the central 
slices showing low distortion were analyzed. For each patient and 
each set of images the ADC values, SUV, dose and HU per voxel (voxel 
size: 27 mm3) were recorded of each volume. 
Results:  
 The average initial ADC value obtained for tumour and node volumes 
(Fig. 1A) of two first patients was 1,29·10-3 mm2/s and can be fitted to 
a Gaussian curve with a FWHM = 0,73·10-3 mm2/s (Fig. 1B). Histograms 
show a displacement to the right after radiotherapy sessions.  
Considering only voxels with initial ADC in the range ± FWHM/2, and 
SUV >3 for the first patient, and >1 for the second one, and averaging 
for each volume, we obtain an increment of ΔADC with dose for both 
patients (Fig. 1B). The justification of different thresholds in SUV is 
because the differences in SUV histograms (Fig. 1B).  
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In the lower graph (Fig. 1C), we can observe an increase in ΔADC as 
dose increases, although the data are not relevant enough because of 
the few number of patients analyzed. 
Conclusions: ADC maps can be used not only for treatment 
assessment, but also for quantification of tumour response voxel by 
voxel. Even more, the joint use of MRI diffusion data and PET/CT can 
be useful for delimiting the hypoxic areas, due to glucose 
consumption enhancement by Pasteur effect. The main weakness of 
this method is the rigid registration process, and non rigid registration 
algorithms are needed for the registration of highly distorted images 
from diffusion studies. 
Supported by ISCIII Grant PI11/02035. 
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Purpose/Objective: In radiotherapy (RT) of prostate cancer the key 
organs at risk (ORs) – the rectum and the bladder – display 
considerable motion, which may influence the dose/volume 
parameters predicting for morbidity. In this study we compare motion-
inclusive doses to planned doses for the rectum and bladder and 
explore their associations with prospectively recorded morbidity.  
Materials and Methods: The study included 38 prostate cancer 
patients treated with hypo-fractionated image-guided intensity-
modulated RT that had an average of nine repeat CT scans acquired 
during treatment. These scans were registered to the respective 
treatment planning CT (pCT) followed by a new dose calculation from 
which motion-inclusive dose distributions were derived. The pCT 
volumes, the treatment course averaged volumes as well as the 
planned and motion-inclusive doses were associated with acute and 
late morbidity (morbidity cut-off: ≥ Grade 2). 
Results: Acute rectal morbidity (observed in 29% of cases) was 
significantly associated with both smaller treatment course averaged 
rectal volumes (population median: 75 vs. 94 cm-3) and the motion-
inclusive volume receiving doses close to the prescription dose (2Gy-
equivalent dose of 76 Gy).  
Conclusions: Variation in rectum and bladder volumes leads to 
deviations between planned and delivered dose/volume parameters 
that should be accounted for to improve the ability to predict 
morbidity following RT.  
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Purpose/Objective: Biomarkers extracted from functional images may 
be subject to cross-institutional variations, and are thus in need of 
standardization. Pharmacokinetic parameters derived from dynamic 
contrast enhanced (DCE) MRI of cervical cancers have shown a 
predictive value in identifying patients at risk of relapse following 
radiotherapy. The aim of the current work was to compare 
pharmacokinetic parameters obtained from DCEMR images, acquired 
at different institutions, of patients with locally advanced cervical 
cancers. 
Materials and Methods: DCEMRI images from 2 centers have so far 
been collected. At center 1 (Oslo University Hospital), 78 patients 
have been included. Here, DCEMRI was performed using Magnevist 
(Gadopentetate Dimeglumine) as contrast agent and an FSPGR 
sequence with temporal resolution of 15 s and spatial resolution of 
0.8x0.8x5 mm at a 1.5T Signa Horizon LX scanner (GE Medical 
Systems). At center 2 (University Medical Center, Utrecht), 23 
patients have been included. In this case, DCEMRI was performed 
using Magnevist and a 3D FLASH sequence with 2.4 s temporal 
resolution and spatial resolution 0.9x0.9x3mm at a 1.5T Gyroscan NT 
Intera scanner (Philips Medical Systems). Pharmacokinetic analysis 
with the ‘Brix’ model was performed in an identical manner for the 
two cohorts. The model analysis of the dynamic series was done voxel 
by voxel in the tumors, providing maps of the ABrix (amplitude), kep 
and kel parameters. The median of a given parameter was extracted 
for each patient, in addition to a relative measure of tumor 
heterogeneity (difference between 66th and 33rd percentile, divided by 
the median). Cohort data for each center was compared using Mann-
Whitney tests. P-value<0.05 was considered statistically significant. 
Results: The cohort-based median values for center 1 versus center 2 
was 2.20 vs 3.41 (relative units), 1.59 vs 0.68 (min-1) and 0.076 vs 
0.080 (min-1) for ABrix, kep and kel, respectively. For the heterogeneity 
measure, values obtained were 0.40 vs 0.55, 0.54 vs 0.99 and 1.10 vs 
1.70, respectively. Non-significant differences were only found for 
median values of kel. 
Conclusions: Five out of six pharmacokinetic tumor parameters 
obtained from DCEMRI performed at the two different institutions 
were significantly different in this preliminary analysis, possibly 
pointing at differences in MR scanners and acquisition protocols. We 
aim at including patients from more institutions, at introducing the 
‘Tofts’ pharmacokinetic model and at using reference tissue for 
normalization. Furthermore, data are to be analyzed in a multivariate 
setting, accounting for variations in stage, tumor volume and other 
relevant clinical factors. 
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Purpose/Objective: Nowadays, quantitative 3D Ultrasound (US) Image 
Guided Radiotherapy (IGRT) systems are available which can assess 
absolute volumetric information on soft tissue. Acquiring daily US 
images is quick and imposes no extra radiation burden to the patient. 
For intramodality US systems only the reference CT (planning) image 
is available. Nevertheless, CT images for every treatment fraction 
would be useful, e.g. for dose recalculation, and assessing margins. To 
this end, deformable image registration (DIR) was applied to calculate 
the deformation field between reference and daily US images. This 
field was then applied to the reference CT.  
Materials and Methods: To validate the procedure a deformable 
phantom was developed, existing of a PMMA box filled with 
demineralized water, containing two balloons filled with either saline 
solution or sunflower oil with a variable volume. Four different 
configurations were imaged with CT as well as US. Deformation fields 
are computed between several pairs of US images and then applied to 
the corresponding CT of the first US of the pair (see figure). This 
reconstructed new, matching CT for the second US is then compared 
to the real corresponding CT of the second US using the sum of 
squared differences (SQD) metric. The deformation fields are 
calculated using an elastic registration algorithm (REGGUI; morphons). 
The SQD metric was limited to the area where US information was 
available.  
